Dernièrement…

▶️ Retrouvez l’interview de @fabriceplasson pour @LyonDecideurs tournée lors de l’événement Lyon Pôle Bourse le 28 septembre dernier. #biocontrole #news #strategie

📣 Communiqué de Presse : https://bit.ly/3UjM17U
C’est officiel ! Les équipes d’#Amoéba sont heureuses de vous annoncer que l’#US EPA a approuvé l’utilisation du lysat d’amibe Willaertia magna C2c Maky comme #substance active utilisable en #agriculture aux #USA. 🌱

📣 Communiqué de Presse : https://bit.ly/3EWyVc2
🌱 #Amoéba a le plaisir d’annoncer la publication des #résultats d’#essais en champ 2022, une année record en nombre et en performance avec plus de 120 essais réalisés ou en cours à travers le monde

📣 Communiqué de Presse: https://bit.ly/3Th8RwF
💧#Amoéba retire son dossier #biocide au #Canada afin de concentrer nos ressources sur les priorités #stratégiques, telles que le déploiement de notre agent #biocontrôle en Europe et aux USA et du biocide en circuits fermés aux USA

Amoéba: US regulatory calendar update

Amoéba updates the regulatory calendar for both the biocide and biocontrol applications in the US.

Lyon (France), May 30, 2022 – 17h45 – AMOÉBA (FR0011051598 – ALMIB), producer of a biological biocide capable of eliminating bacterial risk in water and human wounds, and of a biocontrol product for plant protection, still in development phase, updates the regulatory calendar for both the biocide and biocontrol applications in the US.

Application for authorization of the biocide in the United States

The application for approval of the biocidal active substance, the living amoeba Willaertia magna C2c Maky, and biocidal products containing it, filed in April 2021 with the U.S. Environmental Protection Agency (U.S. EPA), is still under review. The conclusions were, according to the legal deadline announced by the authority, expected by mid-2022. The U.S. EPA has requested an extension of the assessment period: the conclusions of the assessment should now be available in the second half of 2022.

Application for authorization of the biocontrol in the United States

The application for approval of the biocontrol active substance, the lysate of Willaertia magna C2c Maky, and the biocontrol products containing it, filed in October 2020 with the U.S. Environmental Protection Agency (EPA), is still under review. The conclusions were, according to the legal deadline announced by the authority, expected by the end of May 2022. The U.S. EPA has requested an extension of the assessment period: the conclusions of the assessment should now be available in the second half of 2022.